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http:WHAT THIS PAPER ADDS
During bypass surgery, preservation of vascular grafts in preservation solutions (saline or Custodiol) causes
endothelial dysfunction, leading to an enhanced rate of complications and unfavourable early and late outcome
(e.g., early graft thrombosis, vasospasm, restenosis, and occlusion). Additionally, there are unavoidable situa-
tions in vascular or transplantation surgery in which a long ischaemic period is necessary and therefore current
storage protocols need further improvement. We proved in our model that vardenaﬁl-enriched solution efﬁ-
ciently preserved the endothelium after long-term cold ischaemic storage and warm reperfusion, and could be a
new therapeutic option for an optimal preservation of vascular grafts.Objective: Based upon the well known protective effect of intracellular cyclic guanosine monophosphate (cGMP)
accumulation, we tested the hypothesis that storage solution enriched with optimal concentration of the
phosphodiestherase-5 inhibitor vardenaﬁl could provide better protection of vascular grafts against reperfusion
injury after long-term cold ischaemic storage.
Methods: Isolated thoracic aorta obtained from rats underwent 24-h cold ischaemic preservation in physiological
saline or vardenaﬁl (1011 M)-supplemented saline solution. Reperfusion injury was simulated by hypochlorite
(200 mM) exposure for 30 minutes. Endothelium-dependent vasorelaxation was assessed, and histopathological
and molecularebiological examination of the aortic tissue were performed.
Results: Compared with the control group, the saline group showed signiﬁcantly attenuated endothelium-
dependent maximal relaxation (Rmax) to acetylcholine after hypoxia-reoxygenation, which was signiﬁcantly
improved by vardenaﬁl supplementation (Rmax control: 98  1%; saline: 48  6%; vardenaﬁl: 75  4%; p < .05).
Vardenaﬁl treatment signiﬁcantly reduced DNA strand breaks (control: 10.6  6.2%; saline: 72.5  4.0%;
vardenaﬁl: 14.2  5.2%; p < .05) and increased cGMP score in the aortic wall (control: 8.2  0.6; saline:
4.5  0.3; vardenaﬁl: 6.7  0.6; p < .05).
Conclusions: Our results support the view that impairment of intracellular cGMP signalling plays a role in the
pathogenesis of the endothelial dysfunction induced by cold storage warm reperfusion, which can be effectively
reversed by pharmacological phosphodiesterase-5 inhibition.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Prevention of ischaemia and reperfusion (I/R) injury in
cardiac surgery is an important issue in the ﬁeld of tissue
and organ protection, as I/R is a determining factor of acute
and chronic graft failure.1 Just as for other organs, coldse authors contributed equally to this work.
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//dx.doi.org/10.1016/j.ejvs.2013.05.006ischaemic storage conservation solution is preferable to
avoid the loss of functional integrity of vascular grafts.
Regarding the importance of graft patency, several different
storage solutions for intraoperative short-time conservation
of free vascular grafts have been tested in the past. Grafts
are likely to be stored between 4 C and room temperature
in heparinised blood, saline and, rarely, in histidine-
triptophane-ketoglutarate (HTK or Custodiol) or University
of Wisconsin solutions. The basic concept behind the usual
cold ischaemic storage is the suppression of metabolic
activity. The deleterious side of this preservation method is
cell swelling, acidosis and release of reactive oxygen species
(ROS).2 Although some studies have indicated the superi-
ority of HTK solution compared with Ringer and saline
G. Veres et al. 243solutions for storing saphenous vein grafts,3,4 the poor long-
term preservation capacity of HTK solution has been
demonstrated by an in vitro coronary artery model.5 How-
ever, saline or HTK solutions are spread in clinical routine.
In vascular grafts during reperfusion injury due to myelo-
peroxidase released from activated leucocytes, the produc-
tion of ROS and other related oxidants reaches pathological
levels.6 ROS-like hypochlorous acid and peroxynitrite attack
various biomolecules in the vasculature, causing DNA strand
breakage, mitochondrial function disruption, lipid peroxida-
tion induction, and depletion of antioxidant reserves.7 First
and foremost, the enhanced formation of ROS originating
from the leucocyteeendothelial cell interactions affects the
endothelium, resulting in endothelial and, consequently,
vascular dysfunction.8 Such dysfunction manifests in the
impaired production of the thrombocyte activation inhibitor
prostacycline, and in the decreased ability of vasodilatation
caused by the inhibition of the nitric oxide (NO)ecyclic
guanosine monophosphate (cGMP)ecGMP-dependent pro-
tein kinase (PKG) pathway. This pathway is shown to have a
considerable role in vascular- and cardioprotection.9,10
Intracellular cGMP accumulation is proven to reduce tissue
injury in conditions associated with increased free radical
release and oxidative stress.11,12
Vardenaﬁl is a selective phosphodiesterase (PDE)-5 in-
hibitor that hinders the degradation of cGMP by inhibiting
its predominant regulator enzyme. Vardenaﬁl was shown to
have beneﬁcial effects against myocardial I/R injury after
preconditioning-like treatment in rabbits13 and an advan-
tageous protective effect on vascular endothelium.1,14 The
protective effect of PDE-5 inhibition on endothelial
dysfunction following I/R injury was also demonstrated in a
human study, although sildenaﬁl was used.15
Based upon the well known protective effect of intra-
cellular cGMP accumulation, this study aimed to test the
hypothesis that storage solution enriched with an optimal
concentration of vardenaﬁl could provide better protection
of vascular grafts against reperfusion injury after long-term
cold ischaemic storage.
METHODS
Please see the Supplementary material for further details
on the quantiﬁcation of terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labelling (TUNEL) and
cGMP stainings, evaluation of quantitative real-time poly-
merase chain reaction (qRT-PCR), and Western blotting.Animals
Male SpragueeDawley rats (250e330 g; Charles River,
Sulzfeld, Germany) were housed in a room at a constant
temperature of 22  2 C with 12-hour light/dark cycles,
and were fed a standard laboratory rat diet; water was
available ad libitum. All procedures concerning animals
conformed with the Guide for the Care and Use of Labo-
ratory Animals prepared by the Institute of Laboratory
Animal Resources and published by the National Institutes
of Health (NIH Publication No. 86-23, revised 1996). Theinvestigations were reviewed and approved by the local
ethics committee for animal experimentation.
Experimental groups and treatment. Rats were euthanised
by overdose of sodium pentobarbital before exsanguination.
The left chamber was pierced with a 4G needle, and 20 mL
conservation solution was infused at a speed of 1 mL/second
transcardially to wash out any blood from the aorta. Ac-
cording to the experimental groups, this conservation solu-
tion was cold KrebseHenseleit solution (118 mmol/L sodium
chloride, 4.7 mmol/L potassium chloride [KCl], 1.2 mmol/L
potassium hydrogen phosphate, 1.2 mmol/L magnesium
sulphate, 1.77 mmol/L calcium chloride, 25 mmol/L sodium
bicarbonate, and 11.4 mmol/L glucose; pH ¼ 7.4), saline, or
vardenaﬁl solution (1011 M). Thoracic aorta was excised
carefully, cleaned from connective tissue, and cut transversely
into 4-mm-wide rings under an operation microscope. Special
attention was paid to avoid damaging the endothelium.
Aortic rings were stored in 4 C for 24 hours in 5mL cold saline
or 1011 M vardenaﬁl-containing tubes. The tubes were
previously equilibrated for 15 minutes with NO to extrude
oxygen from the solution. Aortic rings in the saline group
received the same treatment, but with only saline transcardial
perfusion and no vardenaﬁl in the storage saline solution.
After 24 hours of ischaemic storage, rings proceeded to the
organ bath. To stimulate free radical burst, which occurs
usually in vivo during reperfusion,16 200 mM hypochlorite
(HOCl) was added for 30 minutes to the baths of the saline
and vardenaﬁl groups. Aortic rings in the control group did
not go through cold ischaemic storage, but were mounted in
an organ bath and received no HOCl exposition.
In vitro organ bath experiments. Isolated aortic rings were
mounted on stainless steel hooks in individual organ baths
(Radnoti Glass Technology, Monrovia, CA, USA), containing
25 mL of KrebseHenseleit solution at 37 C and aerated
with 95% O2 and 5% CO2. Isometric contractions were
recorded using isometric force transducers of a myograph
(159901A; Radnoti Glass Technology), digitised, stored, and
displayed with the IOX Software System (EMKA Technolo-
gies, Paris, France). The aortic rings (n ¼ 15e20 from
N ¼ 8e12 animals in each group) were placed under a
resting tension of 2 g (which was found to be optimal in
preliminary experiments7,17) and equilibrated for 60 mi-
nutes. During this period, tension was adjusted periodically
to the desired level and the KrebseHenseleit solution was
changed every 30 minutes. At the beginning of each
experiment, maximal contraction forces to KCl (80 mM)
were determined and aortic rings were washed until the
resting tension was again obtained. Afterwards, 200 mM
HOCl was added (except the control group) for 30 minutes
to the baths, then washed out. Aortic preparations were
pre-constricted with a-adrenergic receptor agonist phenyl-
ephrine (106 M) until a stable plateau was reached, and
relaxation responses were examined by adding cumulative
concentrations of endothelium-dependent dilator acetyl-
choline (109 to 104 M). For testing the relaxation
response of smooth muscle cells, a direct NO donor, sodium
nitroprusside (1010 to 105 M), was used. Half-maximal
Table 1. Values of maximal relaxation (Rmax,%) and pD2 to
acetylcholine to sodium nitroprusside (SNP), and contraction
forces induced by phenylephrine (106 M) in control, saline, or
vardenaﬁl (1011 M) conserved hypochlorite-exposed thoracic
aortic rings. Values represent mean  standard error of the mean.
Control Saline Vardenaﬁl
Rmax
to acetylcholine
(%)
97.9  0.6 48.3  5.6a 74.8  3.5a,b
pD2
to acetylcholine
7.6  0.1 6.4  0.1a 6.9  0.08a,b
Rmax to SNP (%) 99.98  0.02 99.86  0.1 99.98  0.02
pD2 to SNP 8.3  0.1 8.2  0.1 8.8  0.2a,b
Phenylephrine
(% of KCl)
78.1  2.5 123.5  1.6a 123.6  3.5a
Note. KCl ¼ potassium chloride.
a p < .05 versus control.
b p < .05 versus saline.
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centrationeresponse curves by ﬁtting experimental data to
a sigmoidal equation using Origin 7.0 (Microcal Software,
Northampton, MA, USA). Contractile responses to phenyl-
ephrine are expressed as the percent of the maximal
contraction induced by KCl. The sensitivity to vasorelaxants
was assessed by pD2 ¼ log EC50 (M); vasorelaxation (and
its maximum (Rmax)) is expressed as the percent of
contraction induced by phenylephrine (106 M).
Histopathological processing. Aortic segments from each
experimental group were ﬁxed in paraformaldehyde solu-
tion (4%) and embedded in parafﬁn. The 3-mm-thick sec-
tions were placed on adhesive slides.
TUNEL reaction
Following the manufacturer’s protocol (Chemicon Interna-
tional, Temecula, CA, USA), TUNEL staining was performed
as described previously.17
cGMP immunohistochemical staining. Rehydrated sections
were blocked (3% goat serum) and rabbit polyclonal anti-
cGMP primary antibody (Abcam, Cambridge, UK) incuba-
tion was performed (1:1,000) for 2 hours at room temper-
ature. Tissue sections were incubated overnight at 4 C,18
followed by incubation of secondary biotinylated anti-
rabbit immunoglobulin E (BioGenex, Fremont, CA, USA),
which allowed the alkaline phosphatase-conjugated strep-
tavidin to react (BioGenex). A red reaction product at the
site of the target antigen was formed by Fast Red substrate
(DakoCytomation, Hamburg, Germany). Negative controls
were counterstained with Gill’s haematoxylin.
qRT-PCR. Total RNA was isolated from the chosen aortic
rings with the RNeasy Fibrous Tissue Mini Kit (Qiagen, Hil-
den, Germany) after homogenisation. The concentration
and purity of RNA were determined at 260, 280, and
230 nm with a spectrophotometer. Reverse transcription
was performed with the QuantiTect Reverse Transcription
Kit (Qiagen) using 400 mg RNA in a volume of 20 mL. qRT-
PCR was performed in the LightCycler480 system with
Universal ProbeLibrary probes (Roche, Mannheim, Ger-
many). Primers were obtained from TIB Molbiol (Berlin,
Germany) (see Supplementary Table 1).
Western blotting
Proteins were extracted from tissue homogenates, and
Western blotting was performed for the quantiﬁcation of
p17 caspase-3 fragment (1:1,000), Bax (1:200), and Bcl-2
(1:100; Abcam). Glyceraldehyde-3-phosphate dehydroge-
nase was determined as housekeeping protein (1:500; Santa
Cruz Biotechnology, Heidelberg, Germany). Target protein
densities were normalised to housekeeping densities of the
same sample.
Statistical analysis
Data were tested for normal distribution (ShapiroeWilk)
and where they met the requirements for parametricanalysis, means were tested by analysis of variance and
Bonferroni’s correction test. For the analysis of PCR results
the KruskaleWallis test for multiple comparison was used.
A p-value <.05 was considered statistically signiﬁcant.
RESULTS
Endothelium-dependent and endothelium independent
vasorelaxation of aortic rings
In aortic rings pre-contracted with phenylephrine, acetylcho-
line induced concentration-dependent relaxation. Aortic seg-
ments exposed to cold ischaemic storage followed by HOCl
incubation showed signiﬁcantly attenuated Rmax to acetyl-
choline and signiﬁcant increase of pD2, which implies a shift of
the acetylcholine concentrationeresponse curves to the right
compared with the control group (Table 1, Fig. 1A). Conser-
vation of aortic segments in vardenaﬁl-supplemented saline
solution signiﬁcantly improved the acetylcholine-induced
endothelium-dependent NO-mediated vasorelaxation after
the exposure of rings to HOCl (Table 1, Fig. 1A). There was no
signiﬁcant different in Rmax for endothelium-independent
vasorelaxation of the aortic rings to sodium nitroprusside
between the experimental groups. (Table 1, Fig. 1B).Contractile responses of aortic rings
Contractile responses of aortic rings to phenylephrine
(106 M) are shown in Table 1. Incubation of aortic seg-
ments of saline and vardenaﬁl groups with HOCl signiﬁ-
cantly increased phenylephrine-induced maximum
contraction compared with the control group (78.1  2.5%
vs. 123.5  1.6% vs. 123.6  3.5%, p < .05 control, saline,
and vardenaﬁl groups respectively). However, contractile
responses to high KCl-induced depolarisation did not differ
signiﬁcantly between the experimental groups (Table 1).Vardenaﬁl decreases DNA strand breaks and maintains
intracellular cGMP level
An increased density of TUNEL-positive nuclei indicates DNA
fragmentation in the aortic wall (intima and media) of rings
Figure 1. The effect of vardenaﬁl in in vitro ischaemiaereperfusion on vasomotor function of rat aortic rings. (A) Acetylcholine-induced
endothelium-dependent vasorelaxation; (B) sodium nitroprusside-induced endothelium-independent vasorelaxation are shown in con-
trol, saline, and vardenaﬁl groups. Values represent mean  standard error of the mean. Note. *p < .05 versus control. #p < .05 versus
saline.
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vardenaﬁl-supplemented saline solution signiﬁcantly
decreased DNA strand breaks (Fig. 2A, C).
We detected signiﬁcantly lower cGMP immunoreactivity in
the saline group than in the control group. A signiﬁcantly
higher score of cGMP staining was observed in the vardenaﬁl-
supplemented group than in the saline group (Fig. 2B, D).Figure 2. Effects of vardenaﬁl on DNA strand breaks and cyclic guano
photomicrographs of terminal deoxynucleotidyl transferase-mediated
immunohistochemical staining for cGMP (red staining) in the vessel wa
in vardenaﬁl (1011 M)-conserved thoracic aortic rings; (C) scoring of T
immunohistochemistry (magniﬁcation 200, bar ¼ 50 mm). Values rep
control. #p < .05 versus saline.Vardenaﬁl regulates aortic gene expression
Cold ischaemic conservation of aortic rings followed by 30
minutes HOCl incubation caused statistically relevant up-
regulation in mRNA expression of the vasoconstrictor
endothelin-1 (Fig. 3A) and two apoptotic genes, caspase-3
and bax (Fig. 3B, C), which were signiﬁcantly decreased by
vardenaﬁl. Moreover, the signiﬁcant down-regulation ofsine monophosphate (cGMP) levels in aortic rings. (A) Respective
dUTP nick-end labelling (TUNEL) reaction (brown staining); (B)
ll of control and sodium hypochlorite (NaOCl)-exposed, in saline, or
UNEL staining (in percentage of total cell number); and (D) cGMP
resent mean  standard error of the mean. Note. *p < .05 versus
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group was totally antagonised by vardenaﬁl. Vardenaﬁl
supplementation did not inﬂuence the mRNA level of
endothelial nitric oxide synthase (eNOS) and inducible nitric
oxide synthase (iNOS) (Fig. 3E, F).Effect of vardenaﬁl on cleaved caspase-3 level, and Bax
and Bcl-2 protein expression
Densitometric analysis of caspase-3 p17 cleavage and Bax
bands showed a signiﬁcant increase in the saline group and
was signiﬁcantly moderated by vardenaﬁl supplement
(Fig. 4A, B). Expression of Bcl-2 (Fig. 4C) was signiﬁcantly
decreased in saline group and maintained at the level of
controls when supplemented with vardenaﬁl.
DISCUSSION
The major ﬁnding of this study is that, with respect to
function and structure, long-term storage of rat aortic
segments in a vardenaﬁl-supplemented preservation solu-
tion provides signiﬁcantly better protection against I/R
injury than the most frequently used saline solution. TheFigure 3. Effects of vardenaﬁl in in vitro ischaemiaereperfusion on the
(C) Bax, (D) Bcl-2, (E) endothelial nitric oxide synthase (eNOS), and (F) in
were given the arbitrary value of 1. Values represent median  quartbeneﬁcial effect of vardenaﬁl was demonstrated by
improved vasodilatatory capacity, lower grade DNA strand
breaks, maintained cGMP content, and preserved mRNA
and protein expression.
To simulate the whole reperfusion process the well
established method of reoxygenation and rewarming with
additional HOCl incubation was applied.16,17 After pro-
longed cold storage and high reperfusion levels of ROS,
including other less toxic oxygen species, HOCl is released
from activated leucocytes and severely impairs endothelial
cells and NO production, and induces apoptosis in endo-
thelial cells and in the vessel wall through oxidative stress.
After prolonged cold storage and reperfusion, high levels of
ROS severely impair endothelial cells and NO production.
Damaged endothelial cells are responsible for impaired
vasodilatory graft function and for the developing vascul-
opathy.20,21 Vascular tone (endothelium-dependent vaso-
relaxation) is particularly important in cardiac, as well as in
vascular surgery, as it determines postoperative blood ﬂow
and is responsible for the early and late graft thrombosis
and stenosis.22 Furthermore, the long-term beneﬁt of
revascularisation surgery depends heavily on the long-termgene expression of (A) endothelin-1 (ET-1), (B) caspase-3 (casp-3),
ducible nitric oxide synthase (iNOS) in isolated aortic rings. Controls
iles. Note. *p < .05 versus control. #p < .05 versus saline.
Figure 4. The effects of vardenaﬁl in in vitro ischaemiaereperfusion on protein expression of (A) cleaved caspase-3 (casp-3), (B) Bax, and
(C) Bcl-2 in isolated aortic rings (n ¼ 6 per group). Values represent mean  standard error of the mean. Note. *p < .05 versus control.
#p < .05 versus saline.
G. Veres et al. 247patency of bypass grafts, which is determined by several
factors: the progress of heart/vascular disease, the biolog-
ical properties of the implanted graft, and the degree of I/R
injury.
Ingemansson et al.23 showed weak contractive ability
after administration of U-46619, a TXA2 agonist, after 24
hours of ischaemic storage using University of Wisconsin
solution. Another in vitro study demonstrated decreased rat
coronary vasodilatory capacity after 8 hours of cold storage
in HTK solution.5 Different research groups have aimed to
develop individual methods to maintain vascular function
during storage.17,24 In our laboratory, we demonstrated a
maintained vascular function with new iron chelators after
24 hours of ischaemia.19 In accordance with the literature, in
the present study we also found an impaired vasodilatative
capacity in aortic rings after prolonged cold storage for 24
hours followed by warm HOCl-induced reperfusion injury by
using vitro measurements.16,17 The preserved contraction
and endothelium-independent relaxation indicated that the
impaired vascular response was not a functional deﬁcit of
vascular smooth muscle.
Recently, there has been considerable interest in the role
of the NOesolube-guanylate-cyclase (sGC)ecGMPePKG
pathway in myocardial and endothelial protection.9,25 Pre-
vious studies have reported powerful myocardial protection
by pharmacological PDE-5 inhibition,1,26 by sGC activation,10
and by supplementation of an NO-donor, L-Arginin.27
Intracellular cGMP-accumulation has been shown to
reduce oxidative tissue injury in conditions associated with
increased free radical release and oxidative stress.10 More
recently, the observed cardioprotection with pharmacolog-
ically increased cGMP levels has been reported to be
mediated by hydrogen sulphide signalling in a PKG-
dependent fashion.28 The PKG-dependent cytoprotective
mechanism of vardenaﬁl involves phosphorylation of ERK,
induction of Bcl-2, and opening of mitochondrial KþATP
channels.13,29 We also demonstrated, in the vardenaﬁl-
treated group, up-regulation in both Bcl-2 mRNA and pro-
tein expression parallel to a drop in bax and caspase-3
mRNA expressions, and cleaved caspase-3 level, demon-
strating inhibition of the apoptotic processes, as also evi-
denced by the TUNEL staining results. In this study mRNAexpression of eNOS and iNOS was signiﬁcantly decreased in
the saline and vardenaﬁl groups. Vardenaﬁl treatment had
no effect on these levels. It does not contradict the effect of
the PDE-5 inhibitors, as they act through the suppression of
cGMP degradation, but have no expected direct effect on
NO accumulation. Based on functional improvement we
propose that the reduced intracellular cGMP level plays a
role in the pathogenesis of vascular dysfunction after 24
hours cold storage, which is also supported by the cGMP
immunohistochemistry performed in aortic tissue in this
study. Furthermore, severe DNA damage could also be
effectively prevented by vardenaﬁl, as evidenced by our
TUNEL labelling.
To the best of our knowledge, it has not been previously
tested whether the selective inhibition of PDE-5 would also
be capable of preventing I/R injury after long-term storage.
In conclusion, we report, for the ﬁrst time, that the PDE-5
inhibitor vardenaﬁl added to a preservation solution
restored impaired endothelial function of aortic rings after
long-term cold storage followed by HOCl-induced warm
reperfusion. This work supports the view that PDE5 inhibi-
tion might be advantageous in the treatment of endothelial
dysfunction during long-term storage.Study limitations
The PDE-5 inhibitor vardenaﬁl may have therapeutic po-
tential to lower oxidative stress with the aim of improving
clinical outcome of I/R injury in blood vessels after trans-
plantation. However, in our study, aortic rings were har-
vested ex vivo to examine vascular reactivity without the
involvement of non-aortic tissue, with lack of blood ﬂow
and absence of leucocyte activation. Therefore, conﬁrma-
tion of these observations in vivo is essential. Also, 24 hours
of cold ischaemic storage is validated as part of the well-
established in vitro vascular model of I/R, but is not com-
mon in clinical practice. Moreover, additional studies would
be interesting to investigate the effect of vardenaﬁl on
venous grafts.
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